LIBIDO-50
Testosterone is downstream. The signal starts here.
DHEA and Pregnenolone are hormonal master precursors — the molecules your body converts into testosterone, estrogen, cortisol, and neurosteroids. Their decline begins in your 30s and accelerates each decade. By 50, levels have typically fallen 60–80%. LIBIDO-50 delivers both through sublingual absorption, bypassing the hepatic metabolism that oral forms cannot avoid.
DHEA
Dehydroepiandrosterone — the most abundant steroid in the human body in youth, and one of the most studied. Converts to testosterone and estrogen depending on tissue need. Supports libido, mood, energy, and lean tissue maintenance. Declines 60%+ by age 50.
Pregnenolone
The foundational steroid from which all others derive. Beyond downstream hormone conversion, Pregnenolone itself functions as a neurosteroid: it modulates NMDA receptor activity, supports memory formation, and reduces anxiety through its own receptor interactions.
LIBIDO-50 is formulated primarily for men experiencing andropause. Women produce DHEA and Pregnenolone as well and may benefit, but the dose and intended mechanism are calibrated for the male hormonal profile. Women should discuss appropriate dosing with their healthcare provider.
Yes — DHEA and Pregnenolone supplementation will elevate DHEA-S levels on bloodwork. This is expected and not clinically concerning. Disclose this protocol to your physician if you are being tested for hormonal panels.
Hormonal precursor effects are cumulative. Most men report noticeable improvements in morning energy and drive within 2–3 weeks. Libido improvements typically follow at 3–6 weeks as the hormonal environment shifts.